Cargando…

Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation

Protein aggregation into amyloid fibrils is linked to multiple disorders. The understanding of how natively non-harmful proteins convert to these highly cytotoxic amyloid aggregates is still not sufficient, with new ideas and hypotheses being presented each year. Recently it has been shown that more...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziaunys, Mantas, Sakalauskas, Andrius, Sneideris, Tomas, Smirnovas, Vytautas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916790/
https://www.ncbi.nlm.nih.gov/pubmed/33579016
http://dx.doi.org/10.3390/ijms22041775
_version_ 1783657557273870336
author Ziaunys, Mantas
Sakalauskas, Andrius
Sneideris, Tomas
Smirnovas, Vytautas
author_facet Ziaunys, Mantas
Sakalauskas, Andrius
Sneideris, Tomas
Smirnovas, Vytautas
author_sort Ziaunys, Mantas
collection PubMed
description Protein aggregation into amyloid fibrils is linked to multiple disorders. The understanding of how natively non-harmful proteins convert to these highly cytotoxic amyloid aggregates is still not sufficient, with new ideas and hypotheses being presented each year. Recently it has been shown that more than one type of protein aggregates may co-exist in the affected tissue of patients suffering from amyloid-related disorders, sparking the idea that amyloid aggregates formed by one protein may induce another protein’s fibrillization. In this work, we examine the effect that lysozyme fibrils have on insulin amyloid aggregation. We show that not only do lysozyme fibrils affect insulin nucleation, but they also alter the mechanism of its aggregation.
format Online
Article
Text
id pubmed-7916790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79167902021-03-01 Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation Ziaunys, Mantas Sakalauskas, Andrius Sneideris, Tomas Smirnovas, Vytautas Int J Mol Sci Article Protein aggregation into amyloid fibrils is linked to multiple disorders. The understanding of how natively non-harmful proteins convert to these highly cytotoxic amyloid aggregates is still not sufficient, with new ideas and hypotheses being presented each year. Recently it has been shown that more than one type of protein aggregates may co-exist in the affected tissue of patients suffering from amyloid-related disorders, sparking the idea that amyloid aggregates formed by one protein may induce another protein’s fibrillization. In this work, we examine the effect that lysozyme fibrils have on insulin amyloid aggregation. We show that not only do lysozyme fibrils affect insulin nucleation, but they also alter the mechanism of its aggregation. MDPI 2021-02-10 /pmc/articles/PMC7916790/ /pubmed/33579016 http://dx.doi.org/10.3390/ijms22041775 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ziaunys, Mantas
Sakalauskas, Andrius
Sneideris, Tomas
Smirnovas, Vytautas
Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation
title Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation
title_full Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation
title_fullStr Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation
title_full_unstemmed Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation
title_short Lysozyme Fibrils Alter the Mechanism of Insulin Amyloid Aggregation
title_sort lysozyme fibrils alter the mechanism of insulin amyloid aggregation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916790/
https://www.ncbi.nlm.nih.gov/pubmed/33579016
http://dx.doi.org/10.3390/ijms22041775
work_keys_str_mv AT ziaunysmantas lysozymefibrilsalterthemechanismofinsulinamyloidaggregation
AT sakalauskasandrius lysozymefibrilsalterthemechanismofinsulinamyloidaggregation
AT sneideristomas lysozymefibrilsalterthemechanismofinsulinamyloidaggregation
AT smirnovasvytautas lysozymefibrilsalterthemechanismofinsulinamyloidaggregation